Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Post-traumatic stress disorder is one of the most debilitating — and undertreated — mental health conditions in the United States. An estimated 13 million Americans are living with PTSD in any given year, yet fewer than half receive adequate treatment. First-line therapies like prolonged exposure and EMDR are effective for many, but a significant portion of patients don't respond, drop out, or can't access them at all.
Ketamine is changing that calculation.
Over the past decade, a growing body of clinical research has positioned ketamine — and ketamine-assisted psychotherapy (KAP) — as one of the most promising tools available for treatment-resistant PTSD. This article explains how it works, what the research actually shows, how it compares to established trauma therapies, and what treatment looks like in practice.
Written from a clinical perspective by the team at Isha Health.
PTSD develops when the brain fails to properly process a traumatic experience — not because a person is weak, but because trauma physically alters brain function. The amygdala (the brain's fear center) becomes hyperactive, the prefrontal cortex loses its ability to regulate that fear response, and the hippocampus struggles to contextualize memories correctly. The result is a nervous system that stays locked in a state of threat, even when the danger is long past.
This neurobiological reality is exactly why PTSD is so resistant to talk therapy alone. Intrusive memories, hypervigilance, and avoidance aren't just thought patterns — they're encoded in the brain's architecture. Effective treatment has to work at that level.
Standard first-line treatments include:
For patients who've tried these approaches and found them insufficient — or who can't tolerate the exposure required — ketamine offers a fundamentally different mechanism.
Ketamine's primary mechanism of action is NMDA receptor antagonism. It blocks a specific type of glutamate receptor in the brain, which triggers a cascade of effects that are particularly relevant for trauma:
Ketamine promotes the rapid growth of new synaptic connections — a process called synaptogenesis — by stimulating BDNF (brain-derived neurotrophic factor). In practical terms, this means the brain temporarily becomes more "plastic": more capable of forming new patterns and less rigidly locked into old ones. For PTSD, where the brain has become structurally organized around fear and threat, this window of plasticity is therapeutically significant.
Every time a traumatic memory is recalled, it briefly becomes unstable — a process called reconsolidation. Ketamine may interfere with the reconsolidation of fear memories, making it harder for the brain to re-encode them with the same emotional intensity. This is a key reason why combining ketamine with psychotherapy (KAP) is more effective than ketamine alone: therapy during or immediately after dosing can help replace fear-encoded memories with more adaptive ones.
The glutamate system plays a central role in fear learning and extinction — the process by which the brain "unlearns" a conditioned fear response. Ketamine's effects on glutamate may accelerate fear extinction in ways that SSRIs and benzodiazepines cannot.
At therapeutic doses, ketamine produces a transient dissociative experience — a sense of detachment from one's body, thoughts, and sense of self. For many trauma survivors, this is paradoxically helpful: it creates enough psychological distance from traumatic content to allow it to be processed without the nervous system being overwhelmed. In the context of KAP, a skilled therapist can guide this state toward productive processing.
The evidence base for ketamine in PTSD is earlier-stage than for depression, but it is growing rapidly and the signals are consistently positive.
Key findings:
It's worth being honest about what the research doesn't yet show: long-term durability data is still limited, and the optimal dosing frequency, the ideal psychotherapy pairing, and patient selection criteria are still being refined. This is an evolving field. But the trajectory of the evidence — and the clinical experience of practitioners working in this space — is clearly positive.
These are genuinely different tools, and the honest answer is that they're not fully competing — they're often complementary. But for patients and referring therapists trying to understand where ketamine fits, here's a direct comparison:
Ketamine / KAPEMDRProlonged ExposureMechanismNeuroplasticity, glutamate, reconsolidation disruptionBilateral stimulation + memory activationRepeated trauma exposure to reduce fear responseSpeed of effectRapid (hours to days)Moderate (weeks to months)Moderate to slow (months)Requires trauma exposure?No — can work without direct narrative processingPartial — activates memory brieflyYes — core mechanism requires sustained exposureTolerabilityHigh for many patients; dissociation can be unsettlingGenerally goodOften difficult; high dropoutEvidence for PTSDEmerging but strongStrong (well-established)Strong (gold standard)Best forTreatment-resistant, avoidant, or highly dysregulated patientsMost PTSD presentationsPatients who can tolerate exposureAvailabilityTelemedicine-accessibleRequires trained therapist, often in-personRequires trained therapist, often in-person
For patients who've already tried EMDR or PE and had partial benefit, ketamine can serve as a reset — opening a window of neuroplasticity during which therapy can go deeper. For patients who are too dysregulated or avoidant to engage with trauma-focused therapy at all, ketamine may be the first intervention that makes therapy possible.
Isha Health offers ketamine-assisted psychotherapy through a fully telemedicine model, serving patients in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, and Washington.
Here is what the process looks like:
Before any treatment begins, you'll meet with one of our clinicians for a thorough medical and psychiatric evaluation. We screen for contraindications (uncontrolled hypertension, active psychosis, history of severe dissociative disorders) and assess your specific PTSD presentation, trauma history, prior treatment, and goals.
If you're pursuing ketamine-assisted psychotherapy, you'll have at least one preparation session with a KAP-trained therapist before your first dosing session. This session establishes safety, sets intentions, and prepares you to work with whatever arises during the ketamine experience.
Ketamine is administered as a sublingual lozenge (troche) in your own home, under remote clinical supervision. Sessions typically last 60–90 minutes. You'll be guided to lie down, use an eye mask and headphones, and allow the experience to unfold. Our clinical team is available throughout.
For PTSD specifically, the dosing session itself is often not focused on directly processing trauma — that work tends to happen in integration. The primary goal of the dosing session is to allow the neuroplasticity window to open.
Integration is where the therapeutic work of KAP primarily happens. In the days following a dosing session, the brain is in a heightened state of plasticity — more responsive to new learning, new perspectives, and deeper emotional processing. Integration sessions with your therapist during this window are where insights from the ketamine experience are worked through, trauma material can be revisited with greater safety, and new patterns can be reinforced.
Most patients complete an initial series of 3–6 dosing sessions. Some find lasting relief after a single series; others benefit from periodic maintenance. We work with you — and, where applicable, your existing therapist — to design a care plan that fits your needs.
Ketamine for PTSD is not appropriate for everyone, and we take that seriously. You may be a good candidate if:
You may not be a good candidate if you have active psychosis, uncontrolled cardiovascular disease, active substance use disorder, or a history of severe dissociative episodes outside of trauma contexts.
The single most important predictor of good outcomes in KAP is what you bring to the experience: intention, willingness, and support. Ketamine opens a door — what happens next depends on what you do with it.
If you are a therapist working with clients who have complex or treatment-resistant PTSD, ketamine-assisted psychotherapy may be a meaningful addition to your clinical toolkit — not as a replacement for the therapeutic relationship you've built, but as a way to accelerate and deepen the work.
Isha Health works collaboratively with referring therapists. We can provide ketamine preparation and dosing sessions while your client continues their primary therapeutic work with you. We'll communicate openly about your client's experience and goals, and you can be as involved in the integration process as you and your client choose.
We also maintain a network of KAP-trained therapists through our Find Your KAP Therapist directory for clients who don't yet have a therapist or are seeking someone with specific ketamine-assisted psychotherapy training.
How quickly does ketamine work for PTSD?Many patients report noticeable reductions in hypervigilance and intrusive symptoms within 24–72 hours of their first session. The full therapeutic benefit typically unfolds over the course of an initial series of sessions and the integration work that follows.
Is ketamine covered by insurance for PTSD?Ketamine is not FDA-approved specifically for PTSD. Off-label use is not typically covered by insurance. However, the therapy component of KAP may be reimbursable depending on your plan. We can provide a superbill for out-of-network reimbursement.
Can I do ketamine therapy if I'm already on an SSRI for PTSD?In most cases, yes. SSRIs do not contraindicate ketamine therapy, though we review all medications carefully during your intake evaluation. Certain medications — particularly MAOIs — do require discontinuation before ketamine treatment.
Do I need a formal PTSD diagnosis to access treatment?Yes. We require a clinical assessment establishing a diagnosis before beginning treatment. If you don't have an existing diagnosis, our intake evaluation can help determine whether PTSD is the appropriate framework for your symptoms.
What's the difference between ketamine-assisted psychotherapy and ketamine infusions?Ketamine infusions (typically IV, at a clinic) focus primarily on the pharmacological effects of the drug. KAP integrates structured psychotherapy — before, during, and after dosing — to use the neuroplasticity window therapeutically. For PTSD specifically, the evidence and clinical consensus strongly favor the KAP model over ketamine alone.
PTSD has biological roots that talk therapy alone often can't reach. Ketamine — particularly in the context of ketamine-assisted psychotherapy — works at the neurobiological level, opening a window of plasticity that makes trauma processing more accessible and less overwhelming.
The research is still catching up to the clinical experience, but the signal is clear: for patients who haven't found relief through conventional approaches, ketamine represents one of the most promising options currently available.
If you're in California, New York, Texas, Florida, Colorado, Arizona, Georgia, Oregon, or Washington and want to find out whether ketamine therapy is right for your PTSD, we'd be glad to talk.
Isha Health is a physician-led telehealth practice offering ketamine-assisted psychotherapy for depression, anxiety, PTSD, and other mood disorders. Our clinicians work closely with a network of KAP-trained therapists across the states we serve.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.jpg)
.png)
.jpg)
.png)
.png)
.jpg)
.png)
.png)
.png)
.png)
%202.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)